微生物组在过敏、哮喘和职业性肺部疾病中的作用。

The Role of the Microbiome in Allergy, Asthma, and Occupational Lung Disease.

机构信息

Department of Internal Medicine, Division of Pulmonary, Critical Care, and Sleep, University of Nebraska Medical Center, Omaha, NE, USA.

Nebraska Food for Health Center, University of Nebraska-Lincoln, Lincoln, NE, USA.

出版信息

Curr Allergy Asthma Rep. 2024 Aug;24(8):415-423. doi: 10.1007/s11882-024-01156-8. Epub 2024 Jun 21.

Abstract

PURPOSE OF REVIEW

The human commensal microbiota is now widely accepted as a key regulator of human health and disease. The composition of the mucosal associated microbiota has been shown to play a critical role in the lung health. The role of the mucosal microbiota in the development and severity of allergy, asthma, and occupational lung disease is only beginning to take shape. However, advances in our understanding of these links have tremendous potential to led to new clinical interventions to reduce allergy, asthma, and occupational lung disease morbidity.

RECENT FINDINGS

We review recent work describing the relationship and role of the commensal microbiota in the development of allergy, asthma, and occupational lung disease. Our review primarily focuses on occupational exposures and the effects of the microbiome, both in composition and function. Data generated from these studies may lead to the development of interventions targeted at establishing and maintaining a healthy microbiota. We also highlight the role of environmental exposures and the effects on the commensal microbial community and their potential association with occupational lung disease. This review explores the current research describing the role of the human microbiome in the regulation of pulmonary health and disease, with a specific focus on the role of the mucosal microbiota in the development of allergy, asthma, and occupational lung disease.

摘要

目的综述

人类共生微生物群已被广泛认为是人类健康和疾病的关键调节剂。黏膜相关微生物群的组成被证明在肺部健康中起着关键作用。黏膜微生物群在过敏、哮喘和职业性肺病的发展和严重程度中的作用才刚刚开始显现。然而,我们对这些联系的理解的进步具有巨大的潜力,可以为减少过敏、哮喘和职业性肺病发病率提供新的临床干预措施。

最近的发现

我们综述了最近描述共生微生物群在过敏、哮喘和职业性肺病发展中的关系和作用的工作。我们的综述主要集中在职业暴露及其对微生物组的影响,包括组成和功能。这些研究产生的数据可能会导致开发针对建立和维持健康微生物组的干预措施。我们还强调了环境暴露的作用及其对共生微生物群落的影响,以及它们与职业性肺病的潜在关联。本综述探讨了目前描述人类微生物组在调节肺部健康和疾病中的作用的研究,特别关注黏膜微生物群在过敏、哮喘和职业性肺病发展中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd80/11297072/dde51ecfcc09/11882_2024_1156_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索